Dolcetto: The shy Italian
Dolcettos are underappreciated.
Dolcettos are underappreciated, said Eric Asimov in The New York Times. Produced in the Langhe region of northwestern Italy, they’re often passed over by oenophiles for flashier Piedmontese cousins made from the nebbiolo grape. But the dolcettos below are superb everyday wines, each offering an object lesson in earthiness, a lightly tannic texture, and “the very Italian push-pull of blending bitter and sweet.”
2010 Luigi Einaudi Dolcetto Di Dogliani Superiore Vigna Tecc ($23). This wine’s “superb” structure offers “a beautiful balance of sweet, bitter, and earthy.”
2010 Anna Maria Abbona Dolcetto Di Dogliani Sorí dij But ($17). This “forthright” dolcetto is “so fresh and lively that it seemed to want to leap out of the glass.”
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
2011 Aldo Conterno Langhe Dolcetto Masante ($22). This “bright, round” wine offers “a captivating tension between fruity and bitter.”
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Create an account with the same email registered to your subscription to unlock access.
-
Today's political cartoons - May 4, 2024
Cartoons Saturday's cartoons - reflections in the pond, riding shotgun, and more
By The Week US Published
-
5 high-caliber cartoons about Kristi Noem shooting her puppy
Cartoons Artists take on the rainbow bridge, a farm upstate, and more
By The Week US Published
-
The Week Unwrapped: Why is the world running low on blood?
Podcast Scientists believe universal donor blood is within reach – plus, the row over an immersive D-Day simulation, and an Ozempic faux pas
By The Week Staff Published